Loading…
Wednesday April 30, 2025 9:15am - 10:00am PDT
Uncover the critical elements of a robust due diligence process that enables pharma, biotech, and VC leaders to identify opportunities, mitigate risks, and lay the groundwork for successful collaborations and investments.

  • Examine innovative approaches to scientific, financial, and operational assessments during due diligence.
  • Understand how cross-functional collaboration enhances efficiency and reduces blind spots in deal evaluation.
  • Explore lessons from real-world deals where due diligence transformed outcomes and maximized value.
Moderators
avatar for Chris Lew

Chris Lew

Principal, Rock Health
Speakers
avatar for Mankit Law

Mankit Law

Senior Director, Business Development, Search & Evaluation, GSK
avatar for Lindsey Wanner

Lindsey Wanner

Associate General Counsel, IP Alliance and Due Diligence at Gilead Sciences, Gilead Sciences
avatar for Mike Myers

Mike Myers

Associate Vice President, Lilly Research Labs, Due Diligence, Eli Lilly and Company
Wednesday April 30, 2025 9:15am - 10:00am PDT
Town & Country Ballroom A Town & Country Resort, 500 Hotel Cir N, San Diego, CA 92108, USA

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link